首页> 外国专利> NEW POLIPEPTIDES AND PEPTIDES, NUCLEIC ACIDS THAT CODIFY THEM, AND ITS USE IN THE FIELD OF TUMOR THERAPY, INFLAMMATION OR IMMUNOLOGY.

NEW POLIPEPTIDES AND PEPTIDES, NUCLEIC ACIDS THAT CODIFY THEM, AND ITS USE IN THE FIELD OF TUMOR THERAPY, INFLAMMATION OR IMMUNOLOGY.

机译:新的多肽和多肽,可将其编码的核酸及其在肿瘤治疗,炎症或免疫学领域的用途。

摘要

THE INVENTION REFERS TO: A POLYPEPTIDE THAT CONTAINS IN THEIR PEPTIDIC CHAIN THE AMINO ACID SEQUENCE OF 311 AMINO ACIDS OF FIG. 3, OR A FRAGMENT OF THIS SEQUENCE, BEING THE FRAGMENT THAT MAY PRODUCE ANTIBODIES ABLE TO FORM A COMPLEX WITH THE AMINO ACID SEQUENCE OF FIG. 3, OR AN AMINO ACID SEQUENCE THAT HAS A PERCENTAGE OF HOMOLOGY OF AT LEAST 50%, PREFERABLY 75%, AND MORE ADVANTAGE 90% WITH THE AMINO ACID SEQUENCE OF FIG. 3, AND TO PHARMACEUTICAL COMPOSITIONS CONTAINING, AS AN ACTIVE SUBSTANCE, AT LEAST ONE OF THE POLYPEPTIDES OF THE INVENTION OR THE ANTAGONISTS OF THE POLYPEPTIDES OF THE INVENTION AS ANTI-NUMBER COMPOUNDS, OR ANTIINFLAMATORY COMPOUNDS OR ASSOCIATION OF THE TYPE B, AS COMPOUNDS FOR BONE REPAIR AS INDUCERS OF IMMUNOSUPPRESSOR CELLS, AS INHIBITORS OF THE ANTI-COLONIA STIMULATION FACTOR; OR AS TRIPANOCID AGENTS; OR PART OF THE POLYPEPTIDES OF THE INVENTION ABLE TO JOIN THE RECEIVER BEFORE DEFINED.
机译:本发明涉及:在其肽链中包含图1的311个氨基酸的氨基酸序列的多肽。图3的片段,或该序列的片段,是可能产生能够与图1的氨基酸序列形成复合物的抗体的片段。图3所示的氨基酸序列,或者具有图3所示的氨基酸序列具有至少50%,优选75%,并且更优选90%的同源性的氨基酸序列。 3,并且包含作为活性物质的至少一种本发明的多肽或本发明的多肽的拮抗剂作为抗药性化合物或抗炎性化合物或B型抗炎化合物的组合物的药物组合物骨修复作为免疫抑制细胞的诱导剂,作为抗结肠炎刺激因子的抑制剂;或作为三乙酸类药物;本发明的多肽的一部分或一部分能够在定义之前加入受体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号